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MADR1, a MAD-Related Protein
That Functions in BMP2 Signaling Pathways
Pamela A. Hoodless,* Theo Haerry,² Shirin Abdollah,* each other's biological activities (Padgett et al., 1993;
Sampath et al., 1993). In Xenopus, BMP4 ventralizesMark Stapleton,² Michael B. O'Connor,²
early mesoderm and acts as a negative regulator ofLiliana Attisano,*³ and Jeffrey L. Wrana*
neuralization (Harland, 1994; Sasai et al., 1995; Wilson*Program in Developmental Biology
and Hemmati-Brivanlou, 1995). In the mouse, deletionand Division of Gastroenterology
of the BMP4 gene leads to early embryonic lethality withThe Hospital for Sick Children
defects in mesoderm formation (Winnier et al., 1995),Toronto, Ontario
while mice lacking the BMP2 type I receptor, ALK3, failCanada M5G 1X8
to form mesoderm at all (Mishina et al., 1995).²Department of Molecular Biology and Biochemistry
BMPs and other members of the TGFb superfamilyand Developmental Biology Center
interact with a family of related transmembrane Ser/ThrUniversity of California, Irvine
kinase receptors, known as type I and type II. ExtensiveIrvine, California 92717
analysis of TGFb and activin receptors has demon-
strated that signal transduction requires the formation
of a heteromeric complex of type I and type II receptorsSummary
(reviewed by MassagueÂ et al., 1994). For both TGFb and
activin, ligand bound to receptor II is recognized byComponents of the signaling pathways that lie down-
receptor I, which is then phosphorylated by the receptorstream of Ser/Thr kinase receptors and are required
II kinase, thereby allowing propagation of the signal tofor signaling by theTGFb superfamily have been poorly
downstream components (Attisano et al., 1996; Wranadefined. The Drosophila gene Mothers against dpp
et al., 1994). The identification of amino acid substitu-(Mad) and the C. elegans sma genes are implicated in
tions that can constitutively activate type I receptors forthese signaling pathways. We show that MAD func-
TGFb and activin and the ability of these receptors totions downstream of DPP receptors and is required
signal biological responses in the absence of ligand andfor receptor signaling. Phosphorylation of MADR1, a
receptor II further support the model that the type Ihuman homolog of MAD, is tightly regulated and rap-
receptor is the downstream signaling component of theidly induced by BMP2, but not TGFb or activin. This
receptor complex (Attisano et al., 1996; Wieser et al.,phosphorylation is necessary for function, since a
1995). BMPs that also form heteromeric complexes withpoint mutant that yields a null phenotype in Drosophila
type II and type I receptors display a variation on thisis not phosphorylated. BMP2 treatment results in ac-
model, in that type I receptors such as the mammalian
cumulation of MADR1 in the nucleus. MAD proteins
ALK3 and ALK6 and the Drosophila DPP receptor, Thick
may thus define a novel class of signaling molecules
veins (TKV), bind ligand on their own (Koenig et al., 1994;with nuclear function in Ser/Thr kinase receptor sig-
Liu et al., 1995; Nohno et al., 1995; Penton et al., 1994;naling pathways.
Rosenzweig et al., 1995; ten Dijke et al., 1994). Neverthe-
less, the same requirement for formation of heteromeric
complexes in signaling by BMPs has been demon-
Introduction strated for the Drosophila type II receptor Punt and the
type I receptors TKV and Saxophone (SAX) (Letsou et
Bone morphogenetic proteins (BMPs) are members of al., 1995; Ruberte et al., 1995).
the transforming growth factor b (TGFb) superfamily of Beyond thedetermination of the mechanism of activa-
growth and differentiation factors and have been identi- tion of Ser/Thr kinase receptors, little is known about
fied in a wide variety of organisms ranging from insects the downstream components in the signal transduction
to mammals (Kingsley, 1994; Roberts and Sporn, 1990). machinery. Thus, understanding how cells respond to
Many of the BMPs were first identified by their osteoin- TGFb-related ligands remains a central question in the
ductive properties, inducing ectopic bone formation field. Genetic studies in Drosophila have indicated that
when exogenously implanted in rat muscle (Rosen and schnurri, a gene that encodes putative zinc finger tran-
Thies, 1991) and are important in regulating skeletal scription factor, plays a downstream role in DPP signal-
development (Kingsley, 1994; Storm et al., 1994). BMPs ing (Arora et al., 1995; Grieder et al., 1995; Staehling-
also play a role in inductive interactions during the early Hampton et al., 1995), although the molecules involved
development of both vertebrates and invertebrates (re- in regulating Schnurri are not known. Several proteins
viewed by Kingsley, 1994; Harland, 1994). For example, that interact directly with receptors have been identified,
in Drosophila, Decapentaplegic (DPP), Screw, and 60A primarily by yeast two-hybrid screens, and include
are implicated in the regulation of cell fate throughout FKBP-12, TRIP-1, and farnesyl±protein transferase-a
development (Padgett et al., 1987; Wharton et al., 1991; (Chen et al., 1995; Kawabata et al., 1995b; Wang et
Arora et al., 1994). dpp, the best characterized of these al., 1994, 1996). However, none of these studies has
genes, is most closely related to mammalian BMP2 and demonstrated the essential requirement for any of these
BMP4, and these factors can functionally substitute for molecules in signal transduction. Recently, TAK1, a po-
tential component of both TGFb and BMP4 signaling
pathways, has been described as a member of the mito-³Present address: Department of Anatomy and Cell Biology, Univer-
sity of Toronto, Toronto Ontario, Canada M5S 1A8. gen-activated protein (MAP) kinase family (Yamaguchi
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et al., 1995). Thus, a previously unknown protein kinase most of the extracellular domain, TKV(DE-Q199D), re-
sults in similar dominant phenotypes, suggesting thatcascade might be involved in signaling by TGFb and its
related factors. the observed phenotypes do not require ligand binding
(unpublished data). In a particular enhancer piracy line,A genetic approach in Drosophila to identify possible
genes that might mediate DPP signaling has led to the a reduced and blistered wing (Figure 1B) is produced
as a result of ectopic TKV signaling in certain cells ofisolation of the gene Mothers against dpp (Mad) (Raftery
et al., 1995; Sekelsky et al., 1995). Interestingly, Mad the wing imaginal disk (Figure 1F), since in normal wing
discs TKV is expressed in a very different pattern (Brum-displays strong similarity to three Caenorhabditis ele-
gans genes, sma-2, sma-3, and sma-4, which, along mel et al., 1994).
We have used these dominant phenotypes to examinewith daf-4 (a BMP type II receptor), have been implicated
in the formation of dauer larvae (Savage et al., 1996). the epistatic relationship of Mad to tkv. We expect that
a reduction in the levels of downstream componentsThe C. elegans sma-2 gene appears to act in the same
cell as the DAF-4 receptor, a finding that suggests that could suppress the activated tkv phenotype, whereas
mutations in upstream components would not affect theMAD-related proteins are important for signal transduc-
tion. However, none of these proteins displays any flow of ectopic signal and therefore would not suppress
the phenotype. To examine whether reduced levels ofknown protein structural motifs, and, although they ap-
pear to be involved in DPP/BMP function, it is not clear Mad suppressed dominant tkv phenotypes, we crossed
different Mad alleles (Mad1, Mad6, Mad12, MadP-23D, andhow they might function.
In this report, we show that signaling by a constitu- Df[2L]C28) to the homozygous enhancer piracy line
shown in Figure 1. We observed almost complete sup-tively active BMP type I receptor, TKV, is suppressed
in Drosophila heterozygous for mutant alleles of Mad, pression of the blistered phenotype in an animal hetero-
zygous for the small deficiency that removes Mad (Fig-indicating that MAD functions downstream of the TKV
receptor. We also describe the identification of MADR1, ure 1E). In addition, heterozygosity for either the Mad1
or Mad6 alleles suppresses the phenotype almost asa mammalian homolog of MAD, and show that it is rap-
idly phosphorylated in a BMP2-dependent manner that well as the deficiency (Figure 1C), whereas Mad12 and
MadP-23D show slightly weaker suppression (Figure 1D).is specific for BMPs and is not induced by TGFb or
activin. Furthermore, a point mutant of MADR1 corre- In control crosses, we found that heterozygosity for
schnurri, encoding another putative downstream com-sponding to a Mad null allele abolishes this BMP2-
induced phosphorylation. We also describe the sub- ponent in the DPP signaling pathway (Arora et al., 1995;
Grieder et al., 1995), also suppressed the blistered wingcellular localization of MADR1 and demonstrate that
treatment of cells with BMP2 leads to an accumulation phenotype, while heterozygosity for punt, encoding the
DPP type II receptor (Letsou et al., 1995; Ruberte et al.,of the protein in the nucleus. These findings indicate
that MAD and MAD-related molecules are essential 1995) whose function is biochemically upstream of TKV,
shows no suppression (data not shown). A suppressioncomponents of Ser/Thr kinase receptor signaling path-
ways and may function in the nucleus. of phenotype by heterozygosity for Mad was also ob-
tained in other tissues using GAL4±UAS-induced domi-
nant phenotypes (data not shown), indicating that the
Results suppression was not tissue specific and it was unlikely
that MAD was acting at the transcriptional level to re-
Mad Mutations Suppress Dominant tkv Phenotypes duce the expression of the activated TKV. The ability of
MAD has been implicated in the generation of a DPP reduced levels of Mad to suppress the dominant pheno-
response in Drosophila, although its precise function is types produced by ectopic or excess TKV activity (or
not known (Raftery et al., 1995; Sekelsky et al., 1995). both) is most consistent with a model in which MAD is
To investigate whether MAD lies downstream of DPP a postreceptor component required for DPP signaling.
receptors, we used an epistasis test in Drosophila to
position MAD function relative to the Drosophila BMP
receptor encoded by the tkvgene. A constitutivelyactive Identification of a Mammalian Homolog of MAD
To determine human homologs for MAD, we searchedform of the TKV receptor, TKV(Q199D) was expressed
in certain developing tissues using both the GAL4±UAS a database of expressed sequence tags (Lennon et al.,
1996). This search identified several sequences dis-system devised by Brand and Perrimon (1993) and the
enhancer piracy method devised by Noll et al. (1994). playing high levels of identity to MAD. We therefore
obtained several of these clones and determined theIn many instances, dominant adult phenotypes were
produced as the result of ectopic or excessive levels of sequence of a full-length cDNA clone as well as several
overlapping partial clones.TKV signaling (or both). When lines that express GAL4
in eye, leg, or wing imaginal discs were used to drive The 1658 bp segment of contiguous nucleotide se-
quence that was obtained contains an open readingexpression of either DPP, activated TKV(Q199D), or wild-
type TKV, similar dominant phenotypes were observed frame that is predicted to encode a protein of 455 amino
acids with a molecular mass of 52.3 kDa (Figure 2). Thein flies expressing either DPP or TKV(Q199D) that were
not observed in flies expressing the wild-type receptor predicted protein is highly related to Drosophila MAD,
and thus we have termed this protein MADR1, for MAD-(T. H. and M. B. O., unpublished data). These observa-
tions suggest that the activated receptor sends a signal related 1. A search of the NCBI database with the full
coding sequence revealed that MADR1 is also relatedthat is equivalent to that produced by the ligand itself.
In addition, expression of an activated TKV that lacks to human DPC4, a recently identified gene shown to be
MADs in Ser/Thr Kinase Receptor Signaling
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Figure 1. Suppression of a Dominant
tkv (Q199D) Phenotype by Mad
(A) Wild-type wing of the line UAS±
tkv (Q199D)7-2.
(B) Heterozygous enhancer piracy line
TAJ3/1 showing a blistered wing phenotype.
(C±E) Suppression of the blistered phenotype
in animals heterozygous for Mad mutations:
Mad1/1, TAJ3/1 (C), Mad12/1, TAJ3/1 (D),
and Df(2L)C28/1, TAJ3/1 (E).
(F) Horseradish peroxidase staining of a TAJ3
third instar wing imaginal disc using antibody
against the HA tag at the carboxyl terminus
of the activated TKV.
mutated in some human pancreatic cancers (Hahn et BMP2-Dependent Phosphorylation of MADR1
BMP2 and DPP can functionally substitute for eachal., 1996), as well as the C. elegans MAD-related genes
sma-2, sma-3, and sma-4 (Savage et al., 1996). Align- other, and MADR1 and MAD are closely related, thereby
suggesting that DPP/BMP signaling pathways may bement of MADR1, MAD, and DPC4 revealed that human
MADR1 is more closely related to Drosophila MAD (76% highly conserved. Thus, to determine the regulation and
function of MADR1 in Ser/Thr kinase receptor signaling,identity) than it is to the human DPC4 gene (42% identity;
Figure 2), thereby suggesting that MADR1 is likely to be we focused on the BMP2 pathway. To investigate this,
we constructed a mammalian expression vector encod-the mammalian homolog of MAD.
Closer inspection of these sequences showed that ing MADR1 that was modified to include a FLAG epitope
at the amino terminus (FLAG±MADR1). Epitope tags atthese proteins had no identifiable structural motifs, as
described previously (Sekelsky et al., 1995). However, this position in MAD do not disturb its functional proper-
ties in vivo (Sekelsky et al., 1995). To study MADR1we observed that the highest degree of conservation
occurs in the amino and carboxyl termini. In these do- in mammalian cells, we utilized a highly transfectable
epithelial cell line, L17 (Attisano et al., 1996), that ex-mains, which we term MH1 and MH2 (for MAD homol-
ogy), MAD and MADR1 are approximately 90% identical presses no or low levels of BMP receptors but is respon-
sive to BMP2 and BMP7 when cotransfected with the(Figure 2). It is also within these regions that DPC4 is
most closely related to MADR1 (approximately 55%). appropriate type II and type I receptors (Liu et al., 1995;
Yamashita et al., 1995). In mammalian cells, ActR-IIB,The central regions of these proteins are more divergent
and are particularly rich in serine, threonine, and proline like the DPP type II receptor, Punt (Letsou et al., 1995),
is a high affinity activin receptor, but it also efficientlyresidues.
Figure 2. Sequence Comparison of MADR1,
MAD, and DPC4
Alignment of the predicted amino acid se-
quences of MADR1, MAD, and DPC4. Con-
served residues are highlighted on black, and
gaps introduced to maximize the alignment
are shown as dots. Amino acid residues are
numbered at the right. The MH1 and MH2
regions at the amino and carboxyl termini that
correspond to the highest degree of identity
among MADR1, MAD, and DPC4 are indi-
cated (MH1, solid overline; MH2, broken ov-
erline).
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binds BMP7 when expressed alone (Yamashita et al.,
1995) or BMP2 when coexpressed with the BMP2 type
I receptors, ALK3 or ALK6 (L. A and J. L. W, unpublished
data). Thus, to explore the possibility that MADR1 is
a target of BMP2 signaling pathways, L17 cells were
transiently transfected with FLAG±MADR1 either alone
or with ActR-IIB, ALK3, or both. Immunoblotting with
anti-FLAG antibody of total cell lysates prepared from
these transfected cells showed that MADR1 was ex-
pressed at approximately equal levels in all transfec-
tants and migrated with an Mr of 60K (Figure 3A).
To determine whether MADR1 phosphorylation is reg-
ulated by BMP2, we immunoprecipitated transiently ex-
pressed FLAG±MADR1 from cells labeled with [32P]phos-
phate using anti-FLAG antibodies. In cells expressing
MADR1 alone, basal phosphorylation of the protein was
low (Figure3A). Treatmentwith BMP2 for 15min resulted
in little or no change in this basal level. Furthermore,
when cells were cotransfected with either a type II or
a type I BMP2 receptor alone, no change in MADR1
phosphorylation was observed both in the presence and
absence of ligand. In contrast, in cells coexpressing
ActR-IIB and ALK3 and stimulated with BMP2, there
was a dramatic increase in MADR1 phosphorylation to
greater than 20-fold over basal levels (Figures 3A and
3B). This increase in phosphorylation correlated with
the appearance of a slower-migrating form of MADR1
in Western blots of total lysates, a characteristic often
observed for hyperphosphorylated proteins. We also
observed that a small proportion of MADR1 expressed
in control cells migrated at a slightly slower mobility,
which is likely due to a small proportion of MAD exhib-
iting some basal phosphorylation. During the course
of these experiments, we consistently observed that
coexpression of ActR-IIB and ALK3 led to ligand-inde-
pendent increases in MADR1 phosphorylation, which
may result from the productive interactions known to
occur when type II and type I Ser/Thr kinase receptors
are expressed at elevated levels (Attisano et al., 1996;
Chen and Weinberg, 1995; Liu et al., 1995). Alternatively,
these cells may express low levels of BMP2 that could
function in an autocrine manner to stimulate phosphory-
lation.
To characterize the kinetics of BMP2-dependent
phosphorylation of MADR1, we treated [32P]phosphate-
labeled cells with BMP2 for varying time periods. In-
creased MADR1 phosphorylation was first evident 2 min
Figure 3. BMP2-Dependent Phosphorylation of MADR1after addition of BMP2, peaked at 10±20 min, and re-
(A) Ligand-dependent phosphorylation of MADR1. L17 cells tran-mained elevated for up to 2 hr (Figure 3C). Phospho-
siently transfected with FLAG±MADR1 and the indicated combina-
amino acid analysis revealed that phosphorylation oc- tions of ActR-IIB (type II) and ALK3 (type I), were [32P]phosphate
curred predominantly on serine residues with trace labeled and incubated with (plus) or without (minus) 10 nM BMP2
amounts of phosphothreonine detected (Figure 3D). We for 15 min prior to lysis. MADR1 was subsequently purified by immu-
noprecipitation using an anti-FLAG monoclonal antibody and ana-also subjected MADR1 to phosphopeptide mapping.
lyzed by SDS±PAGE and autoradiography (top). The migration ofTryptic digests of MADR1 purified from [32P]phosphate-
phosphorylated MADR1 is indicated (left), and the positions of thelabeled cells stimulated with BMP2 for 15 min yielded
molecular mass markers (in kilodaltons) are shown on the right.one major phosphopeptide that migrated close to the
MADR1 protein in total cell lysates from unlabeled cell cultures
origin in the electrophoretic dimension (Figure 3E). prepared in parallel was detected by immunoblot analysis using the
Analysis of MADR1 phosphorylation using another BMP anti-FLAG antibody (bottom). Note that in cells in which MADR1 is
type II receptor, BMPR-II, that is distantly related to hyperphosphorylated, the protein displays slower migration (indi-
cated as MADR1*).ActR-IIB (Kawabata et al., 1995a; Liu et al., 1995; Nohno
(B) Quantitation of MADR1 phosphorylation. Phosphorimager scanset al., 1995; Rosenzweig et al., 1995) yielded essentially
from (A) were quantitated using ImageQuant software. Phosphateidentical results to those described above for ActR-IIB
incorporated into MADR1 in the presence (closed bars) or absence
(data not shown).
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These studies demonstrate that MADR1 is rapidly receptors, which then signal to downstream targets.
Thus, the specificity of the biological response to TGFb-phosphorylated onserine residues within a single tryptic
peptide in response to BMP2. Together with the finding related factors is dictated by the type I receptor that is
engaged in the complex. This strongly suggests thatthat both type I and type II receptors are required for
the BMP2-dependent phosphorylation of MADR1, these components of the signaling pathway lying downstream
of type I receptors may show specificity in their regula-results strongly suggest that MADR1 is a downstream
component in the BMP2 signal transduction pathway. tion by TGFb, activin, or BMPs.
In addition to ALK3, BMP2 also binds to the type I
receptor ALK6 (ten Dijke et al., 1994) and forms hetero-A Null Allele of Mad Is Not Phosphorylated
To gain direct evidence that phosphorylation is neces- meric complexes with ActR-IIB (L. A. and J. L. W., un-
published data). The kinase domain of these BMP typesary for MAD function in transmitting DPP/BMP2 sig-
nals, we investigated a mutant allele of Mad. In Drosoph- I receptors are highly related (85% identity), suggesting
that these two receptors may activate similar down-ila, Mad10 contains a missense mutation that converts
a highly conserved glycine residue at position 409 to a stream pathways leading toMADR1 phosphorylation. To
examine this, we cotransfected L17 cells with MADR1,serine residue (Sekelsky et al., 1995; Figure 4A). Interest-
ingly, this corresponding glycine residue (at position ActR-IIB, and ALK6 and analyzed MADR1 immunopre-
cipitated from [32P]phosphate-labeled cells that were or372) in the C. elegans Mad-like gene sma-2 is also al-
tered in certain mutant alleles (Savage et al., 1996). were not treated with BMP2 for 15 min. Phosphorylation
of MADR1 was increased in these cells in response toWe examined whether the Mad10 null allele may alter
the regulation of MAD phosphorylation by introduc-
ing the corresponding mutation into MADR1 to gener-
ate MADR1(G419S) (Figure 4A). Both MADR1 and
MADR1(G419S) were expressed at approximately equal
levels. However, analysis of MADR1 immunoprecipi-
tated from [32P]phosphate-labeled cells treated with or
without BMP2 revealed that BMP2-dependent phos-
phorylation of MADR1 was completely abolished in the
G419S mutant (Figure 4B). Furthermore, analysis of
Western blots for MADR1 confirmed that the mobility
shifts associated with phosphorylation of wild-type
MADR1 did not occur with the G419S mutant. Thus,
mutation of a conserved glycine residue in the MH2
domain yields a nonfunctional MAD protein that is inca-
pable of being phosphorylated by BMP2-activated sig-
naling pathways. Together with the observation that this
mutation is null, these results strongly suggest that li-
gand-dependent phosphorylation of MAD/MADR1 is re-
quired for DPP/BMP2 signaling.
Phosphorylation of MADR1 Is Specific
Current evidence indicates that the type II Ser/Thr kinase
receptors function to phosphorylate and activate type I
(open bars) of BMP2 is plotted relative to levels measured in MADR1
purified from control, unstimulated cells. This experiment was re-
peated five times with similar results.
(C) Kinetics of MADR1 phosphorylation. L17 cells were transfected
with either empty vector (pCMV5) or with FLAG±MADR1, ActR-IIB,
Figure 4. A Null Point Mutant of Mad Is Not Phosphorylatedand ALK3, labeled with [32P]phosphate, and stimulated for the indi-
cated times with 10 nM BMP2. MADR1 was purified by immunopre- (A) The amino acid sequence of MADR1 (from amino acid 409 to
431) and the corresponding regions in SMA-2, DPC4, and MAD arecipitation and analyzed by SDS±PAGE and autoradiography.
(D) Phosphoamino acid analysis. Cells cotransfected with FLAG± shown with conserved sequences highlighted (lightly shaded box).
The glycine mutated in Mad10 null alleles and in mutant sma-2 allelesMADR1, ActR-IIB, and ALK3 were labeled with [32P]phosphate and
treated with BMP2 for 15 min prior to isolating MADR1. Phosphory- is shown in bold, and the glycine to serine mutation introduced into
MADR1 (G419S) is indicated (arrow).lated MADR1 was subjected to partial acid hydrolysis, and phos-
phoamino acids were separated by two-dimensional thin-layer elec- (B) L17 cells were transiently transfected with empty vector or with
ActR-IIB, ALK3 (receptors), and either wild-type MADR1 (wt) or mu-trophoresis. The migration of the phosphoamino acid standards is
indicated (pS, phosphoserine; pT, phosphothreonine; pY, phospho- tant MADR1 (G419S). Cells were [32P]phosphate labeled and incu-
bated with (plus) or without (minus) 10 nM BMP2 for 15 min priortyrosine).
(E) Tryptic phosphopeptide mapping of MADR1. MADR1 purified to lysis. MADR1 was purified by immunoprecipitation using an anti-
FLAG monoclonal antibody and analyzed by SDS±PAGE and autora-as described above was subjected to tryptic digestion, and the
phosphopeptides were resolved by electrophoresis in buffer at pH diography (top). Wild-type and mutant protein levels of MADR1 were
analyzed in parallel by immunoblotting total cell lysates using anti-1.9 in the first dimension, followed by chromatography in phos-
phochromatography buffer in the second dimension. The origin of FLAG antibody (bottom). The migration of MADR1 and the slower-
migrating form (marked as MADR1*) are indicated.the sample application is indicated (plus).
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BMP2 and was comparable with that observed in cells
coexpressing ActR-IIB and ALK3 (Figure 5A). The in-
creases in phosphorylation also correlated with the ap-
pearance of slower-migrating forms of MADR1 on West-
ern blots. Thus, both ALK3 and ALK6 can mediate
BMP2-dependent phosphorylation of MADR1.
TGFb and activin signal through the more distantly
related type I receptors, TGFb type I receptor (TbR-I)
and ActR-IB, respectively. To examine the regulation of
MADR1 phosphorylation by these factors, L17 cellswere
cotransfected with MADR1 and either TbR-1 or ActR-
IB. These cells express sufficient endogenous type II
receptors such that they respond to TGFb or activin as
measured by both transcriptional and antiproliferative
responses when transfected with type I receptors alone
(Attisano et al., 1996; CaÂ rcamo et al., 1994; FranzeÂ n et
al., 1993). TGFb or activin treatment of cells expressing
TbR-I or ActR-IB, respectively, resulted in no detectable
change in MADR1 phosphorylation (Figure 5A). Further-
more, we could not detect any alteration in the mobility
of MADR1 in these cells when analyzed by Western
blotting. We confirmed that the receptors were ex-
pressed by immunoprecipitating hemagglutinin (HA)-
tagged receptors from L17 transfectants metabolically
labeled with [35S]methionine (Figure 5A, bottom).
To establish specificity further, we investigated the
regulation of MADR1 phosphorylation by constitutively
active type I receptors. Introduction of a charged residue
into the GS domain of TbR-I or ActR-IB generates a
constitutively active type I receptor that signals TGFb
and activin responses, respectively, in the absence of
ligand and type II receptors (Attisano et al., 1996; Wieser
et al., 1995). To obtain maximal amounts of MADR1 and
activated receptor protein, we utilized COS-1 cells that
drive expression at extremely high levels. As shown
in Figure 5B, immunoprecipitation of MADR1 from
Figure 5. MADR1 Phosphorylation Is Not Induced by TGFb or Ac-[32P]phosphate-labeled COS cells cotransfected with
tivinwild-type or activated TbR-I revealed no change in
Transiently transfected cells were labeled with [32P]phosphate, andMADR1 phosphorylation. Similar results were obtained
MADR1 was purified from cell lysates by immunoprecipitation usingin cells cotransfected with ActR-IB. We also tested
an anti-FLAG antibody and analyzed by SDS±PAGE and autoradiog-
MADR1 phosphorylation in cellscotransfected with acti- raphy ([32PO4]). Total MADR1 protein was assessed by immunoblot-
vated ALK3 or ALK6. We constructed these receptors, ting total cell lysates obtained from unlabeled cultures that were
as described for activated TbR-I and ActR-IB, by intro- prepared in parallel using the anti-FLAG monoclonal antibody
(a-FLAG Western blotting). The migration of MADR1 is indicatedducing an aspartate residue into the corresponding po-
to the left. Receptor expression level was determined by labelingsition of their GS domains. MADR1 phosphorylation was
transfected cells with [35S]methionine ([35S]met) and immunoprecipi-substantially increased in cells cotransfected with these
tating the tagged receptors from cell lysates using anti-HA antibod-activated receptors when compared with their wild-type
ies (a-HA). The migration of the receptors is indicated on the left.
counterparts (Figure 5B). Equivalent expression of all (A) Specificity of MADR1 phosphorylation in L17 cells. L17 cells
receptors was confirmed by immunoprecipitating the were transiently transfected with empty vector (pCMV5) or with
HA-tagged proteins from transfectants metabolically la- FLAG±MADR1 either alone or together with the indicated receptors,
which were HA tagged at the carboxyl termini. Cells were incubatedbeled with [35S]methionine (Figure 5B, bottom). MADR1
for 15 min in the absence of ligand (minus) or in the presence of 10phosphorylation induced by activated BMP receptors
nM BMP2, 1 nM TGFb, or 2 nM activin A (Act), as indicated. Theoccurred on serine residues, and tryptic phosphopep-
position of the slower-migrating form of MADR1 in the lower panel
tide maps (data not shown) demonstrated that the phos- is indicated (MADR1*).
phorylation occurred within a single phosphopeptide (B) Regulation of MADR1 phosphorylation by constitutively active
that migrated similarly to that observed in maps of type I receptors in COS-1 cells. COS-1 cells were transfected with
MADR1 phosphorylated in BMP2-stimulated L17 cells empty vector (pCMV5) as a negative control or with FLAG±MADR1
and the indicated wild-type (wt) or constitutively active (act) type I(see Figure 3E). Together, these data show that MADR1
Ser/Thr kinase receptors.phosphorylation is induced by BMP2 and not TGFb or
activin and indicate that MADR1 is specifically regulated
by distinct Ser/Thr kinase receptor signaling pathways.
and serve as a direct substrate of the receptor I kinaseOur analysis of the regulation and specificity of
domain. To test this, we first examined whether MADR1MADR1 phosphorylation was consistent with the possi-
bility that MADR1 could interact with BMP receptors expressed together with BMP receptors in COS-1 cells
MADs in Ser/Thr Kinase Receptor Signaling
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Figure 6. Nuclear Accumulation of MADR1 by Activation of BMP2-Dependent Signaling Pathways
(Top) Ligand-dependent nuclear accumulation in MC3T3-E1 cells. MC3T3-E1 cells were transfected with FLAG±MADR1 and incubated in the
presence or absence of BMP2 for 1 hr, as indicated. FLAG±MADR1 was localized in the cells by immunofluorescence using the anti-FLAG
M2 antibody and a fluorescein isothiocyanate (FITC)-conjugated secondary antibody. Nuclei, localized by DAPI staining, are shown below
each corresponding FITC micrograph. In the absence of BMP2, fluorescent staining is diffuse, but displays prominent nuclear staining in the
presence of BMP2.
(Bottom) Nuclear localization of MADR1 in the presence of activated ALK3. COS cells were transfected with FLAG±MADR1 alone or with the
constitutively active ALK3 receptor (Q233D), as indicated. FLAG±MADR1 was localized in the cells as described above. Cells transfected with
FLAG±MADR1 alone show diffuse staining, while prominent nuclear staining is observed in the presence of the activated receptor.
could be coimmunoprecipitated. We used several de- transmitting Ser/Thr kinase receptor signals, we investi-
gated the subcellular localization of MADR1. For thesetection methods, including metabolic labeling of cells,
immunoprecipitation followed by Western blotting, and studies we used MC3T3-E1 cells, which express endog-
enous levels of BMP receptors, respond to BMP2, andaffinity labeling of BMP receptor complexes using
[125I]BMP2. In none of these experiments did we detect have a well-spread cytoplasm and distinct nucleus (Ohta
et al., 1992; ten Dijke et al., 1994). To study localization,any interaction of MADs with either individual receptor
subunits or receptor complexes (data not shown). Fur- we transiently transfected these cells with FLAG±
MADR1 and visualized the protein by immunofluores-thermore, in an in vitro kinase assay, MADR1 protein
produced in bacteria was not phosphorylated by acti- cence and the nuclei by counterstaining with 49,6-dia-
midino-2-phenylindole (DAPI). In untreated control cells,vated BMP type I receptors under conditions in which
diffuse immunoreactivity to FLAG±MADR1 was foundreceptor autophosphorylation was readily observed
throughout the transfected cells (Figure 6). However,(data not shown). These data may indicate that MADR1
in transfectants stimulated with 10 nM BMP2 for 1 hr,does not interact with the receptors and is not a direct
FLAG±MADR1 was found in the nucleus with very littlesubstrate. However, these negative results do not rule
or no immunoreactivity detected in the cytoplasm. Weout the possibility that MADR1 association with the re-
also used COS-1 cells to examine MADR1 localizationceptors is transient or unstable or that additional com-
and activated BMP signaling by expressing constitu-ponents may be required for phosphorylation by the
tively active ALK3 (Q233D). Similar to our observationsreceptor kinase in vitro.
with MC3T3-E1 cells, in control COS cells FLAG±MADR1
was observed throughout the cell, whereas in cells ex-
pressing the activated receptor predominantly nuclear
Ligand-Dependent Nuclear Accumulation staining was observed (Figure 6). Thus, the addition of
of MADR1 ligand to MC3T3-E1 cellsor theexpression of a constitu-
The tightly regulated, ligand-dependent phosphoryla- tively active BMP type I receptor in COS cells leads to
tion of MADs combined with our failure to demonstrate an alteration in subcellular localization of MADR1 from
association with the receptors suggests that MADs may a diffuse distribution to a predominantly nuclear local-
function several steps downstream from the receptors. ization. These data indicate that activation of the BMP2
signaling pathway either by ligand or by constitutivelyThus, to gain insight into the role of these proteins in
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active receptors leads to a redistribution of MADR1 into downstream target. This phosphorylation is dependent
on the presence of both BMP type I and II receptors,the nucleus. Thus, MADs may have a nuclear function
in Ser/Thr kinase receptor signaling pathways. consistent with the known requirement for heteromeric
complex formation in Ser/Thr kinase receptor signaling.
Further, BMP2-induced phosphorylation is abolished inDiscussion
MADR1 harboring a mutation identical to the Mad10 null
allele. This provides compelling evidence that the phos-Members of the TGFb superfamily elicit their wide-rang-
phorylation of MADR1 is necessary for DPP/BMP signal-ing and diverse biological responses through hetero-
ing. Thus, we conclude that MAD-related proteins definemeric complexes of type I and type II Ser/Thr kinase
a novel class of signaling molecules that function down-receptors (MassagueÂ et al., 1994; Miyazono et al., 1994).
stream in the Ser/Thr kinase receptor signaling pathway.Studies with TGFb and activin have revealed that recep-
tor activation involves transphosphorylation of receptor
I by receptor II allowing receptor I to propagate the MADs May Function in the Nucleus
signal to downstream effectors (Attisano et al., 1996;
In unstimulated cells, MADR1 is found predominantly
Chen and Weinberg, 1995; Wrana et al., 1994). However,
in the cytosol and does not appear to associate with
despite our detailed understanding of the mechanism
receptor complexes. However, activation of BMP signal-
of receptor activation, the identity and function of down-
ing pathways either by BMP2 addition to cells or by
steam components in the Ser/Thr kinase receptor sig-
expression of an activated BMP type I receptor leads
naling pathways have remained poorly understood.
to an accumulation of MADR1 in the nucleus. The mech-
Genetic approaches in Drosophila to identify proteins
anism underlying this nuclear accumulation is unclear.
that might mediate DPP signaling has led to the isolation
MADR1 may exist in equilibrium with the nuclear com-
of the gene Mad (Raftery et al., 1995; Sekelsky et al.,
partment, and phosphorylation or other signaling events
1995). Here we describe the identification of MADR1, a
may lead to its retention in the nucleus. Alternatively,
mammalian homolog of MAD. Both MAD and MADR1
stimulation of BMP2 signaling pathways could result
are members of a novel family of related molecules that
in the active nuclear translocation of cytoplasmically
includes the products of three C. elegans genes
localized MADR1. Regardless, these results suggest
sma-2, sma-3, and sma-4 and the human DPC4 gene
that MADs may have a nuclear function in Ser/Thr kinase
(Savage et al., 1996; Hahn et al., 1996). Analysis of the
signaling pathways.
sequence of these family members reveals that they
Although MADs do not appear to contain any known
do not appear to contain any known structural motifs.
structural motifs, several potential nuclear targets for
However, comparison between the various members
MADs can be envisioned. In particular, Schnurri, a zinc
reveals the presence of two conserved domains, which
finger±containing transcription factor required for DPP
we have termed MH1 and MH2. These two domains
function (Arora et al., 1995; Grieder et al., 1995; Staeh-
reside in the amino- and carboxy-terminal thirds of the
ling-Hampton et al., 1995) and its putative mammalian
proteins and flank a central region that is highly diver-
homologs, MBP-1 and MBP-2, could be a potential tar-
gent. Within the MH1 and MH2 domains, specific motifs
gets for MAD activity. Interaction of MADs with these
can be found that are absolutely conserved between all
Schnurri-like factors could serve to activate transcrip-
of the known members. The presence of these con-
tion or modify DNA binding activity to bring about the
served motifs could indicate that these domains share a
changes in gene expression associated with DPP/BMP
conserved tertiary structure required for function. Within
activity. An alternative possibility is that MADs them-
this context, it is interesting to note that most of the
selves could represent a novel class of transcription
mutants of Mad, DPC4, sma-2, and sma-3 that have
factors that directly bind DNA and activate transcription.
been characterized map to the same region of the MH2
domain (Hahn et al., 1996; Savage et al., 1996; Sekelsky
et al., 1995). Regulation of MADR1 Phosphorylation
Biochemical and biological studies of receptor activa-
tion have shown that the first step in Ser/Thr kinaseMAD and MADR1 Function Downstream
of DPP/BMP Receptors receptor signaling is initiated within a heteromeric com-
plex of receptors I and II by the transphosphorylationSeveral lines of genetic and biochemical evidence sug-
gest that MAD and MADR1 are directly regulated by the of receptor I by the kinase domain of receptor II. Once
phosphorylated, receptor I then propagates the signalDPP/BMP2 signal transduction pathway and function
to transmit BMP signals from the cytoplasm into the to downstream targets (Wrana et al., 1994). Our obser-
vations on the regulation of MADR1 phosphorylationnucleus. In Drosophila, mutant phenotypes induced by
expression of a constitutively active DPPtype I receptor, by BMP2 signaling pathways are consistent with this
model. Ligand-dependent phosphorylation requiresTKV, can be suppressed in flies heterozygous for null
alleles of Mad. The ability of a reduction in MAD levels coexpression of type II and type I receptors for BMP2
and can be mediated by either ActR-IIB or another dis-to suppress an activated receptor phenotype provides
evidence that MADs function downstream of the recep- tantly related BMP2 type II receptor, BMPR-II. Further,
this phosphorylation can be induced by the two BMP2tor and are required for transmitting BMP signals. In
mammalian cells, MADR1 is rapidly phosphorylated on type I receptors ALK3 or ALK6, which contain highly
related kinase domains (ten Dijke et al., 1994). Finally,a single,specific tryptic phosphopeptide following treat-
ment of cells with BMP2, suggesting it is an immediate constitutively active type I receptors ALK3 and ALK6
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can stimulate phosphorylation of MADR1 in the absence phosphorylation is specific and is not regulated by
TGFb, activin, or their constitutively activated receptorsof coexpressed type II receptors or ligand.
The strong induction of MADR1 phosphorylation sug- supports this notion and provides a demonstration that
type I receptors may elicit divergent biological re-gests that the BMP2-activated signaling pathways are
highly specific and tightly regulated. Although there are sponses by signaling to distinct downstream pathways.
These findings distinguish Ser/Thr kinase receptorsseveral possible explanations, these data are most con-
sistent with the presence of a BMP2-stimulated kinase from a number of other signaling systems. In particular,
receptor tyrosine kinases often utilize common, overlap-cascade. One attractive possibility is that MADR1 could
directly interact with receptor I and be phosphorylated ping pathways to signal diverse responses (Chao, 1992;
Marshall, 1995). Currently, it is not clear to what extentby its activated kinase domain. However, we were un-
able to detect any interactions between MADR1 and the specificity between different Ser/Thr kinase path-
ways will be maintained. In particular, the BMPs repre-BMP receptors. Since association could be transient or
unstable, these negative results do not completely rule sent a large and diverse family that often displays over-
lapping biological responses, and it appears likely thatout a direct interaction of MADs with the receptors.
However, an alternative possibility may also be envi- some overlap in the regulation of MADs may exist. We
are currently investigating this question utilizing MADR1sioned in which MADR1 is the target of a BMP2-acti-
vated cytoplasmic Ser/Thr kinase cascade analogous and a number of other MADR proteins we have recently
identified. The specificity of MADR1 regulation has addi-to theMAP kinase and stress-activatedkinase cascades
(Davis, 1994; Seger and Krebs, 1995). Interestingly, re- tional implications for the putative function of MAD-like
proteins. Since MADR1 is regulated by BMP2 and notcent studies have led to the identification of a MAPKKK,
known as TAK1, that may be involved in signal transduc- TGFb or activin, it may be centrally involved in determin-
ing a BMP-specific response, while other MAD-relatedtion by members of the TGFb superfamily and may be
a component of this putative cascade (Yamaguchi et proteins, such as DPC4, may play analogous roles, me-
diating distinct responses toother members of the TGFbal., 1995). However, the lack of specificity in TAK1 regu-
lation by TGFb versus BMP4 is not consistent with the superfamily. Establishing how MADRs might confer spe-
cific biological responses will require the identificationspecificity that we observe for MADR1 phosphorylation.
The identification of the mechanisms underlying the reg- of downstream effector molecules.
ulation of MADR1 phosphorylation will clearly be an im-
portant goal for future studies. The Function of MAD Phosphorylation
The activation of BMP2 signaling pathways results Our observations lead us to propose a model in which
in the quantitative phosphorylation of MADR1 within a MADs are components of Ser/Thr kinase signaling path-
specific tryptic peptide. This phosphorylation event is ways that are regulated by phosphorylation and may
tightly regulated, and introduction of a single point muta- function in the nucleus. How might phosphorylation
tion into MADR1 that corresponds to the Mad10 allele is function to control MAD activity? Examination of the
sufficient to abolish BMP-induced phosphorylation. This sequence of MAD-related molecules has not revealed
mutation (glycine to serine) is not in a phosphorylation the presence of any known protein structural motifs, so
site, but occurs in a conserved residue and may act to it is difficult to predict how phosphorylation may alter
disrupt thestructure of theMH2 domain, thus preventing MAD function. One possibility is that phosphorylation
the correct recognition of MAD by upstream regulatory alters the interaction of MAD with other molecules, either
molecules. Nevertheless, since this allele also yields a by dissociating an inhibitory moleculeor by driving asso-
null phenotype similar to deficiencies of Mad, these ob- ciation with a downstream effector. By controlling these
servations suggest that ligand-dependent phosphoryla- interactions, phosphorylation could directly mediate nu-
tion of MADs is necessary for BMP signaling and that clear translocation or be required for the putative nu-
phosphorylated MAD is functionally active to transmit clear functions of MAD. Clearly, it will be of great interest
signals to downstream effectors. to identify both upstream and downstream events in
these signaling cascades that connect MADR1 phos-
phorylation and translocation with biological responses.
Specificity of MADR1 Phosphorylation
In a variety of experimental systems, members of the Experimental Procedures
TGFb superfamily can induce quite different biological
responses (Kingsley, 1994; MassagueÂ , 1990; Roberts Construction of Expression Vectors
Clones (50909, 163228, and 54587) were obtained from the ex-and Sporn, 1990). For example, during patterning of the
pressed sequence database (IMAGE; Lennon et al., 1996) and se-early Xenopus embryo, activins can function to induce
quenced (Sequenase 2.0 kit, United States Biochemicals). To ex-dorsal mesoderm, while BMP-4 induces ventral meso-
press a full-length cDNA for MADR1, a nonsense mutation present
derm in prospective epidermis (Harland, 1994). Previous in the one full-length clone (50909) was removed by a two-step
studies showed that type I receptors with highly related PCR using wild-type sense and antisense primers as described
previously (Wrana et al., 1992). To introduce an epitope tag into thekinase domains can mediate similar biological re-
amino terminus of MADR1, a SalI site was introduced into the 59sponses, whereas more distantly related type I recep-
end of the coding sequence of MADR1 by PCR to allow subcloningtors may mediate distinct responses (CaÂ rcamo et al.,
into pCMV5-FLAG, a vector constructed by modifying pCMV5 to1994). Thus, much of the specificity of responses to
contain a FLAG epitope tag with a SalI site at its 39 end. In this
TGFb-like factors may be generated by ligand-depen- construct the first asparagine residue of MADR1 is converted to a
dent activation of heteromeric receptor complexes that glutamine. Generation of the HA1-tagged, activated ALK3 (Q233D),
ALK6 (Q203D), and TKV(Q199D) and the mutant MADR1 (G419S) bycontain distinct type I receptors. Our finding that MADR1
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a PCR-based strategy was as described previously (Attisano et (Brand and Perrimon, 1993) and injected into embryos. Transgenic
animals carrying the activated receptor under UAS control wereal., 1996; Wieser et al., 1995). All PCR-generated constructs were
verified by sequencing of the amplified regions and subcloned into obtained and crossed to several different GAL4 driver lines to gener-
ate dominant adult phenotypes. Since the pUAST vector containspCMV5, a mammalian expression vector, for transient transfection
assays. a basal hsp70 promoter, we also sought to generate dominant phe-
notypes via the enhancer piracy method (Noll et al., 1994). One
insert line was selected and crossed to the D2-3 ªjumpstarterº strainCell Lines and Transfections
(Robertson et al., 1988), and 10,000 progeny were analyzedto obtainThe mink lung epithelial cell line derivative R-1B (L17 clone) was
the homozygous viable TAJ3 insertion line on the third chromosomemaintained in minimal essential media (MEM) containing 10% fetal
that exhibits the blistered and reduced wing phenotype shown incalf serum and nonessential amino acids. L17 cells were transiently
Figure 1. Anti-HA monoclonal antibody 12CA5 was used in combina-transfected with the indicated vectors using a DEAE±dextran
tion with a HRP-coupled secondary antibody to examine the expres-method as described previously (Attisano et al., 1996). COS-1 cells
sion pattern of the activated TKV receptor in this line. The MadP-23Dwere grown in Dulbecco's MEM containing high glucose and 10%
allele is a P element insert in Mad obtained from I. Kiss, whereasfetal calf serum, and cells were transfected as for L17 cells except
the other mutations were as described previously (Sekelsky et al.,that 400 mg/ml DEAE±dextran was used and 10% Nuserum was
1995).included in the transfection mixture. MC3T3-E1 cells were main-
tained in a-MEM containing 10% fetal calf serum and were tran-
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